EIF2AK4 Recombinant Antbody Kit (KD-Validated)
Applications
Reactivity
| Overview | |
| Catalog # | bsm-90230r-50uL |
| Product Name | EIF2AK4 Recombinant Antbody Kit (KD-Validated) |
| Applications |
WB
FCM
IC
|
| Specificity | Knockdown Validated |
| Reactivity | Human, Rat |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | A synthesized peptide derived from human GCN2 |
| Immunogen Range | 1-59/1649 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Affinity Purified |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | -20°C |
| Target | |
| Gene ID | 440275 |
| Swiss Prot | Q9P2K8 |
| Synonyms | EIF2AK4; Eukaryotic Translation Initiation Factor 2 Alpha Kinase 4; GCN2; KIAA1338; EIF-2-Alpha Kinase GCN2; GCN2-Like Protein; Eukaryotic Translation Initiation Factor 2-Alpha Kinase 4; General Control Nonderepressible; GCN2 EIF2alpha Kinase; EIF-2-Alpha Kinase; EC 2.7.11.1; PVOD2 |
| Background | Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution | |
| WB | 1:300-5000 |
| FCM | 1:20-100 |
| IC | 1:1000 |